Powered by

GENFIT Informs its Shareholders of Certain Procedures for the Extraordinary General Meeting of January 13, 2021

Jan 08, 2021 - GlobeNewswire
Board and Executive Moves

- GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases (the “Company” ), today informs its shareholders of certain changes in certain of the participation and organization procedures for the extraordinary general meeting of January 13, 2021 (the “Extraordinary General Meeting” ), following the publication of decree n° 2020-1614 of December 18, 2020 extending and modifying decree n° 202...